Janet Kang
About Janet Kang
Janet Kang is the Director of Clinical Development at Kite Pharma, where she has worked since 2020. She has extensive experience in clinical protocol writing and development, particularly in Oncology and Hematology, and possesses strong communication and problem-solving skills.
Work at Kite Pharma
Janet Kang has been serving as the Director of Clinical Development at Kite Pharma since 2020. In this role, she is responsible for overseeing clinical development activities, which includes managing global clinical trials. Her significant experience in clinical protocol writing and development is essential for ensuring the successful execution of these trials. Kang's contributions have been vital in delivering high-quality results within established timelines.
Previous Experience in Clinical Research
Before joining Kite Pharma, Janet Kang held several key positions in clinical research. She worked at Celgene as Director and Principal Clinical Research Scientist in Oncology/Hematology from 2019 to 2020. Prior to that, she served as Associate Director and Senior Clinical Research Scientist in the same therapeutic area at Celgene from 2018 to 2019. Kang also gained experience at Novartis as an Expert Clinical Manager in Oncology from 2014 to 2017, and as a Senior Clinical Manager from 2011 to 2014.
Education and Expertise
Janet Kang earned her Doctor of Pharmacy (PharmD) degree from Rutgers University, where she studied from 1999 to 2005. Her educational background has provided her with a strong foundation in pharmacy, which complements her extensive experience in clinical research, particularly in Oncology and Hematology. With over eight years of experience in these therapeutic areas, Kang has developed a deep understanding of the complexities involved in clinical trials.
Early Career and Academic Involvement
Janet Kang began her career in clinical research at Roche, where she worked as a Post-Doctoral Fellow in Clinical Research and Development from 2005 to 2007. She continued at Roche as a Clinical Science Specialist in Virology from 2007 to 2011. Additionally, she contributed to academia as an Adjunct Faculty member at the Ernest Mario School of Pharmacy at Rutgers University from 2005 to 2007, sharing her knowledge and expertise with students.